Financials

People

Activity

SLS Venture

Company

Investment-firm

Financing round

General

About Company
SLS Venture is one of the largest investment funds in Scandinavia's life science sector.

Industry

Sector :

Subsector :

Keywords :

IPO status

Private

Description

SLS Venture, a Scandinavian-based venture capital company, is the result of the merger of the life science team from The Sixth Swedish National Pension Fund, Medicon Valley Capital and Innoventus. The fund is one of the largest investment funds in Scandinavia in the life science sector with approx. € 270 M (USD 325 M) under management.
Contacts
Similar Companies
1000
Excalibur Fund Managers

Excalibur Fund Managers

Excalibur Fund Managers is a venture capital firm that invests in medical sciences, biotechnology and life sciences sectors.

Sector

Closed End Investments

Subsector

Closed End Investments

Keywords

Venture Capital, Life Science, Biotechnology

Location

London, UK

count Of Investments

22

count Of Exists

7
Avlar BioVentures

Avlar BioVentures

Avlar BioVentures is a UK-based venture capital firm that invests in seed and early-stage companies in the bioscience industries.

Sector

Closed End Investments

Subsector

Closed End Investments

Keywords

Financial Services, Venture Capital, Biotechnology

Location

Madingley, Cambridge CB23, UK

count Of Investments

13

count Of Exists

1
F2 Ventures

F2 Ventures

F2 Ventures is a venture capital and private equity firm focused on investing in the biotechnology sector.

Sector

Closed End Investments

Subsector

Closed End Investments

Location

London, UK

count Of Investments

19

count Of Exists

3
BioFund Management

BioFund Management

BioFund Management is a pan-Nordic venture capital firm.

Sector

Closed End Investments

Subsector

Closed End Investments

Location

Helsinki, Finland

count Of Investments

11

count Of Exists

5

Financials

Investments
12
Date 
name 
Lead 
type 
Raised 
16.07.2010
No
$6.3M
12.10.2009
Yes
$8M
AdvanDx

AdvanDx

AdvanDx provides molecular diagnostic tests for identifying pathogens causing critical infections in hospitalized patients.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Medical

Location

Woburn, MA, USA

total rounds

7

total raised

$49.7M
Action Pharma

Action Pharma

Action Pharma is a biotech company that develops pharmaceutical products for cardiovascular, inflammatory, and metabolic diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Aarhus, Denmark

total rounds

3

total raised

$34.32M
AdvanDx

AdvanDx

AdvanDx provides molecular diagnostic tests for identifying pathogens causing critical infections in hospitalized patients.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Medical

Location

Woburn, MA, USA

total rounds

7

total raised

$49.7M
Co-Investors
Exits
3
AdvanDx

AdvanDx

AdvanDx provides molecular diagnostic tests for identifying pathogens causing critical infections in hospitalized patients.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Medical

Location

Woburn, MA, USA

total rounds

7

total raised

$49.7M
Nuevolution

Nuevolution

Nuevolution conducts partner-funded drug discovery programs.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Pharmaceuticals, Health Care

Location

Copenhagen, Denmark

total rounds

3

total raised

$33.74M
Symphogen

Symphogen

Symphogen produces recombinant polyclonal antibody drugs for disease treatment and prevention.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

2800 Lyngby, Denmark

total rounds

10

total raised

$375.22M

People

Employee Profiles
3
Mikael Mortensen

Mikael Mortensen

CFO and Partner

Henrik Lawaetz

Henrik Lawaetz

Partner and Managing Director

Per Carendi

Per Carendi

Partner and CEO

Activity

Recent News
0